Wed Jan 29 12:49:58 UTC 2025: ## Singer’s Osteoporosis Diagnosis Spurs Warning on Ozempic Weight Loss
**NEW DELHI** – The rising popularity of the diabetes drug Ozempic for weight loss has prompted a health warning after singer Avery revealed a diagnosis of osteoporosis following a year of using the medication. While Ozempic (semaglutide) effectively manages type-2 diabetes and reduces heart disease risk, its use for rapid weight loss is raising concerns.
Avery’s public announcement highlights potential risks associated with rapid weight loss induced by Ozempic. Dr. Vineet Kumar Surana, Consultant – Diabetes and Endocrinology at Manipal Hospital, explains that significant weight loss can decrease muscle mass and bone density, potentially leading to brittle bones and an increased fracture risk, particularly in older individuals. Although a direct link between Ozempic and osteoporosis requires further research, the impact of rapid weight loss on bone health is undeniable.
Ozempic’s common side effects include nausea, vomiting, diarrhea, abdominal pain, constipation, and fatigue. Less common but serious side effects can include pancreatitis, kidney problems, gallbladder issues, and allergic reactions.
Dr. Surana stresses the importance of monitoring bone health for those using Ozempic. He recommends:
* Regular bone health checks
* Vitamin D level testing (especially for women)
* Addressing underlying conditions impacting bone integrity
* A calcium and vitamin D-rich diet
* Weight-bearing exercise
* Adequate calcium and vitamin D supplementation
While Ozempic works by mimicking the GLP-1 hormone to reduce appetite and calorie intake, resulting in weight loss, Dr. Surana emphasizes that sustainable weight loss is best achieved through a healthy diet and regular exercise. He cautions against relying on medication for rapid weight loss without careful medical supervision. The article concludes with a standard disclaimer emphasizing the importance of consulting a medical professional for personalized advice.
First Piper 